Ingredients

EU R&D keeps active

EU R&D keeps active

There has been 'unprecedented development' in terms of the
Community's research policy in the last year claims the European
Commission's 2002 annual report on technological research and
development (RTD) in 2001.

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...

The yolk of the matter

The yolk of the matter

The prospect of using chicken eggs as commercial 'biofactories' for
the production of protein-based drugs has moved a step closer with
the announcement of a study showing that transgenic cockerels can
pass on an introduced...

Plants ooze vitamin C

Plants ooze vitamin C

Scientists in the US report this week that they have developed a
new technology that increases the amount of vitamin C in plants,
including grains, by increasing the amount of the enzyme that is
responsible for recycling vitamin C.

Sigma Tau with Thuris

Sigma Tau with Thuris

Drug development and biomedical company Thuris and Italian
pharmaceutical company Sigma-Tau Industrie Farmaceutiche Riunite on
Monday announced an expansion of their ongoing research
collaboration to develop compounds to combat brain...

Research pursuits

Research pursuits

Drug discovery company Pharmacopeia and healthcare business
AstraZeneca have extended their research collaboration. The
companies announced this week that they will shift their efforts
from the generation of screening libraries to...

Agreement in 3DP

Agreement in 3DP

3-Dimensional Pharmaceuticals (3DP) said this week that the
research term under its thrombin collaboration with two of the
Johnson & Johnson family of companies, Centocor and Johnson
& Johnson Pharmaceutical Research and Development,...

Inflammation investigated

Inflammation investigated

US Pharmacopeia has entered into a research collaboration focused
on inflammation with Celgene Corporation. The companies will work
together to identify promising small molecule lead compounds
suitable for further development.

Shea nut to beat swellings

Shea nut to beat swellings

Danish vegetable oils and fats company Aarhus Oliefabrik announced
yesterday that together with Astion, it will increase the
development portfolio of BSP Pharma principally using oil from the
African shea nut.

Ecopia discovery

Ecopia discovery

Canadian drug development company Ecopia BioSciences on Monday
announced that it had filed patent applications for the first two
novel compounds using its proprietary drug discovery platform -
suggesting investments by the company...

Follow us

Products

View more

Webinars